News
DNPUF
10.50
NaN%
--
Sumitomo Pharma Co., Ltd. GAAP EPS of ¥268.99, revenue of ¥453.29B
Seeking Alpha · 05/13 17:41
Sumitomo Pharma Profit Surges on Higher Revenue and Cost Controls
TipRanks · 05/13 04:33
Sumitomo Pharma Issues Cautious FY2025 Results Conference Materials
TipRanks · 05/13 04:33
Sumitomo Pharma Ends Major Equity Offering, Withdraws Share Issuance Shelf
TipRanks · 04/27 02:52
Sumitomo Pharma Sets Terms for Over ¥100 Billion Equity Offering
TipRanks · 04/20 08:53
Sumitomo Pharma Refinances Guaranteed Debt With New Bridge Loan
TipRanks · 04/08 07:37
Sumitomo Pharma Launches Major Share Offering to Strengthen Financial Base
TipRanks · 04/08 07:37
Sumitomo Pharma to Book ¥48.3 Billion Dividend as Non-Operating Income With No Group Profit Impact
TipRanks · 03/25 07:02
Sumitomo Pharma Wins Conditional Japan Approval for First iPS Cell-Derived Parkinson’s Therapy
TipRanks · 03/06 00:22
Sumitomo Pharma Launches ‘Boost 2028’ Plan to Build on V-Shaped Recovery
TipRanks · 03/02 06:57
Sumitomo Pharma Lifts Full-Year Profit Outlook on Strong GEMTESA Sales and Weaker Yen
TipRanks · 03/02 06:57
Sumitomo Pharma Files ¥140 Billion Shelf Registration to Fund Growth and Bolster Finances
TipRanks · 03/02 06:57
Sumitomo Pharma shares slide nearly 16% despite panel backing for iPS-derived parkinson’s treatment
Seeking Alpha · 02/20 11:20
Sumitomo Pharma Posts Surging Profit and Higher Revenue in Q3 FY2025 Under IFRS
TipRanks · 01/30 07:13
Sumitomo Pharma Outlines Q3 FY2025 Results With Caution on Forward-Looking Data
TipRanks · 01/30 07:13
Jefferies Sticks to Their Buy Rating for Sumitomo Dainippon Pharma Co (DNPUF)
TipRanks · 12/16/2025 12:16
Sumitomo Pharma Reports Strong Half-Year Results and Raises Full-Year Forecasts
TipRanks · 10/31/2025 07:12
Sumitomo Pharma Completes Strategic Sale in Asian Business Restructuring
TipRanks · 10/31/2025 07:12
Trump’s 100% drug tariffs send pharma stocks lower
Seeking Alpha · 09/26/2025 08:59
Weekly Report: what happened at DNPUF last week (0908-0912)?
Weekly Report · 09/15/2025 10:56
More
Webull provides a variety of real-time DNPUF stock news. You can receive the latest news about DAI Nippon Pharm through multiple platforms. This information may help you make smarter investment decisions.
About DNPUF
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.